Literature DB >> 15353588

Molecular basis for catecholaminergic neuron diversity.

Jan Grimm1, Anne Mueller, Franz Hefti, Arnon Rosenthal.   

Abstract

Catecholaminergic neurons control diverse cognitive, motor, and endocrine functions and are associated with multiple psychiatric and neurodegenerative disorders. We present global gene-expression profiles that define the four major classes of dopaminergic (DA) and noradrenergic neurons in the brain. Hypothalamic DA neurons and noradrenergic neurons in the locus coeruleus display distinct group-specific signatures of transporters, channels, transcription, plasticity, axon-guidance, and survival factors. In contrast, the transcriptomes of midbrain DA neurons of the substantia nigra and the ventral tegmental area are closely related with <1% of differentially expressed genes. Transcripts implicated in neural plasticity and survival are enriched in ventral tegmental area neurons, consistent with their role in schizophrenia and addiction and their decreased vulnerability in Parkinson's disease. The molecular profiles presented provide a basis for understanding the common and population-specific properties of catecholaminergic neurons and will facilitate the development of selective drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15353588      PMCID: PMC518849          DOI: 10.1073/pnas.0405340101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

Review 1.  It could be habit forming: drugs of abuse and striatal synaptic plasticity.

Authors:  Gregory L Gerdeman; John G Partridge; Carl R Lupica; David M Lovinger
Journal:  Trends Neurosci       Date:  2003-04       Impact factor: 13.837

Review 2.  Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells.

Authors:  Ronald R Fiscus
Journal:  Neurosignals       Date:  2002 Jul-Aug

Review 3.  The neurobiology of sleep: genetics, cellular physiology and subcortical networks.

Authors:  Edward F Pace-Schott; J Allan Hobson
Journal:  Nat Rev Neurosci       Date:  2002-08       Impact factor: 34.870

4.  The coupling of a trkB tyrosine residue to LTP.

Authors:  Patrik Ernfors; Clive R Bramham
Journal:  Trends Neurosci       Date:  2003-04       Impact factor: 13.837

Review 5.  The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction?

Authors:  Antonello Bonci; Giorgio Bernardi; Pernilla Grillner; Nicola B Mercuri
Journal:  Trends Pharmacol Sci       Date:  2003-04       Impact factor: 14.819

6.  Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans.

Authors:  Kunio Kitamura; Masako Yanazawa; Noriyuki Sugiyama; Hirohito Miura; Akiko Iizuka-Kogo; Masatomo Kusaka; Kayo Omichi; Rika Suzuki; Yuko Kato-Fukui; Kyoko Kamiirisa; Mina Matsuo; Shin-ichi Kamijo; Megumi Kasahara; Hidefumi Yoshioka; Tsutomu Ogata; Takayuki Fukuda; Ikuko Kondo; Mitsuhiro Kato; William B Dobyns; Minesuke Yokoyama; Ken-ichirou Morohashi
Journal:  Nat Genet       Date:  2002-10-15       Impact factor: 38.330

Review 7.  Hyperprolactinemia: etiology, diagnosis, and management.

Authors:  Peak Mann Mah; Jonathan Webster
Journal:  Semin Reprod Med       Date:  2002-11       Impact factor: 1.303

Review 8.  Schizophrenia as a disorder of neurodevelopment.

Authors:  David A Lewis; Pat Levitt
Journal:  Annu Rev Neurosci       Date:  2002-03-22       Impact factor: 12.449

9.  Lipoprotein lipase affects the survival and differentiation of neural cells exposed to very low density lipoprotein.

Authors:  Eric Paradis; Sébastien Clement; Pierre Julien; M R Ven Murthy
Journal:  J Biol Chem       Date:  2002-12-24       Impact factor: 5.157

10.  Induction of the learning and plasticity-associated gene Zif268 following exposure to a discrete cocaine-associated stimulus.

Authors:  Kerrie L Thomas; Mercedes Arroyo; Barry J Everitt
Journal:  Eur J Neurosci       Date:  2003-05       Impact factor: 3.386

View more
  60 in total

Review 1.  Biochemical premotor biomarkers for Parkinson's disease.

Authors:  Brit Mollenhauer; Jing Zhang
Journal:  Mov Disord       Date:  2012-04-15       Impact factor: 10.338

2.  An endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease.

Authors:  Chee Yeun Chung; James B Koprich; Shogo Endo; Ole Isacson
Journal:  J Neurosci       Date:  2007-08-01       Impact factor: 6.167

3.  Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection.

Authors:  Chee Yeun Chung; Hyemyung Seo; Kai Christian Sonntag; Andrew Brooks; Ling Lin; Ole Isacson
Journal:  Hum Mol Genet       Date:  2005-05-11       Impact factor: 6.150

Review 4.  Strategies to unravel molecular codes essential for the development of meso-diencephalic dopaminergic neurons.

Authors:  F M J Jacobs; S M Smits; K J M Hornman; J P H Burbach; M P Smidt
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

Review 5.  Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity.

Authors:  F Tribl; K Marcus; G Bringmann; H E Meyer; M Gerlach; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  2006-07-13       Impact factor: 3.575

Review 6.  Cellular excitability and the regulation of functional neuronal identity: from gene expression to neuromodulation.

Authors:  David J Schulz; Richard A Baines; Chris M Hempel; Lingjun Li; Birgit Liss; Hiroaki Misonou
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

7.  Improved RNA preservation for immunolabeling and laser microdissection.

Authors:  Amanda L Brown; Doug W Smith
Journal:  RNA       Date:  2009-10-22       Impact factor: 4.942

8.  Loss of PINK1 attenuates HIF-1α induction by preventing 4E-BP1-dependent switch in protein translation under hypoxia.

Authors:  William Lin; Natasha L Wadlington; Linan Chen; Xiaoxi Zhuang; James R Brorson; Un Jung Kang
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

9.  Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression.

Authors:  Chee Yeun Chung; James B Koprich; Penelope J Hallett; Ole Isacson
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-10       Impact factor: 11.205

10.  Neuroprotective therapy in Parkinson's disease: current status and new directions from experimental and genetic clues.

Authors:  William Lin; Un Jung Kang
Journal:  J Clin Neurol       Date:  2005-10-20       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.